Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A1805 in Continuous Renal Replacement Therapy (CRRT)
CTR20260249Phase 3Active
- Sponsor
- Qingshan Likang Pharmaceutical
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trisodium citrate in acute kidney failure (AKF), Renal failure (RF), sponsored by Qingshan Likang Pharmaceutical. Started Jan 2026; status: active.
02
Drugs
trisodium citrate
03
Conditions
acute kidney failure (AKF)Renal failure (RF)
Beyond the preview
Go deeper on CTR20260249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260249.